Trupanion (TRUP) Projected to Post Earnings on Wednesday

Key Points

• Trupanion is expected to announce its Q3 2025 earnings on October 29, with anticipated earnings of $0.06 per share and revenue of $361.575 million.
• The stock is currently trading at approximately $44.02, with a 12-month price range of $31.00 to $57.90, reflecting its market cap of $1.89 billion.
• Analysts have mixed ratings on Trupanion, with two recommending a Buy, four a Hold, and a consensus target price of $53.80.

Trupanion (NASDAQ:TRUP - Get Free Report) is anticipated to post its Q3 2025 results before the market opens on Wednesday, October 29th. Analysts expect Trupanion to post earnings of $0.06 per share and revenue of $361.5750 million for the quarter. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS.Individuals may review the information on the company's upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, November 6, 2025 at 4:30 PM ET.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.03) by $0.25. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The firm had revenue of $353.56 million during the quarter, compared to the consensus estimate of $346.73 million. During the same quarter in the previous year, the business earned ($0.14) earnings per share. The firm's quarterly revenue was up 12.3% compared to the same quarter last year. On average, analysts expect Trupanion to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Trupanion Price Performance

TRUP stock opened at $44.02 on Wednesday. The stock has a 50-day moving average price of $44.56 and a two-hundred day moving average price of $45.73. Trupanion has a 12-month low of $31.00 and a 12-month high of $57.90. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.32. The company has a market cap of $1.89 billion, a PE ratio of 169.31 and a beta of 1.83.

Insider Buying and Selling

In related news, CEO Margaret Tooth sold 8,961 shares of the business's stock in a transaction dated Thursday, September 25th. The stock was sold at an average price of $41.88, for a total value of $375,286.68. Following the transaction, the chief executive officer owned 144,229 shares in the company, valued at approximately $6,040,310.52. The trade was a 5.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Darryl Rawlings sold 30,369 shares of the business's stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $44.70, for a total value of $1,357,494.30. Following the completion of the transaction, the director owned 1,413,281 shares in the company, valued at approximately $63,173,660.70. This trade represents a 2.10% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 61,761 shares of company stock worth $2,739,621. 5.42% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of TRUP. Tidal Investments LLC acquired a new position in shares of Trupanion in the second quarter worth about $212,000. Brevan Howard Capital Management LP acquired a new stake in Trupanion during the second quarter valued at approximately $236,000. Gabelli Funds LLC acquired a new stake in Trupanion during the second quarter valued at approximately $249,000. Tower Research Capital LLC TRC raised its stake in Trupanion by 490.6% during the second quarter. Tower Research Capital LLC TRC now owns 4,754 shares of the financial services provider's stock valued at $263,000 after buying an additional 3,949 shares in the last quarter. Finally, Nebula Research & Development LLC acquired a new stake in Trupanion during the second quarter valued at approximately $266,000.

Analyst Upgrades and Downgrades

TRUP has been the subject of several analyst reports. Cantor Fitzgerald raised Trupanion to a "hold" rating in a research report on Wednesday, August 13th. Stifel Nicolaus upped their target price on Trupanion from $41.00 to $45.00 and gave the stock a "hold" rating in a research report on Friday, August 8th. Piper Sandler upped their target price on Trupanion from $62.00 to $67.00 and gave the stock an "overweight" rating in a research report on Friday, August 8th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Trupanion in a research report on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, Trupanion presently has a consensus rating of "Hold" and an average target price of $53.80.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.